Medications and Cardiovascular Health in Older Adults: Room for Improvement in Prevention and Treatment
| Autor: | Caroline S. Rhoads, Curt D. Furberg, Jean L. Olson, Bruce M. Psaty |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Drug
Health Knowledge Attitudes Practice medicine.medical_specialty media_common.quotation_subject Hyperlipidemias Disease Lower risk Risk Factors Atrial Fibrillation Hyperlipidemia Diabetes Mellitus Humans Medicine Intensive care medicine Stroke Antihypertensive Agents Aged Hypolipidemic Agents media_common Heart Failure business.industry Health Policy Atrial fibrillation medicine.disease Cardiovascular Diseases Heart failure Hypertension Cohort Physical therapy Geriatrics and Gerontology Cardiology and Cardiovascular Medicine business Gerontology |
| Zdroj: | The American Journal of Geriatric Cardiology. 13:161-167 |
| ISSN: | 1751-715X 1076-7460 |
| Popis: | While cardiovascular disease remains the most common cause of death in older adults, treatments are now available that are associated with significant improvements in both morbidity and mortality. The Cardiovascular Health Study trials of drug use in older adults reviewed here show that in a racially and geographically diverse cohort of community-dwelling elders, effective treatments were underused during the 1990s. Most participants with hyperlipidemia, atrial fibrillation, and congestive heart failure did not receive therapies known to reduce morbidity and mortality, and when treatment was initiated, those at highest risk were no more likely to start treatment than those at lower risk. The use of drugs with evidence of efficacy in the prevention of stroke and congestive heart failure in hypertensive participants decreased with time, and control of hypertension and hyperlipidemia were particularly low in diabetics. The impact of this undertreatment on older persons and on society is likely to be substantial. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text